Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
27.40
-1.44 (-4.99%)
Sep 11, 2026, 4:08 PM HKT
Hanx Biopharmaceuticals (Wuhan) Employees
Hanx Biopharmaceuticals (Wuhan) had 60 employees as of June 30, 2026. The number of employees increased by 5 or 9.09% compared to the previous year.
Employees
60
Change
5
Growth
9.09%
Revenue / Employee
1.40K HKD
Profits / Employee
-2.53M HKD
Market Cap
3.73B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 60 | 5 | 9.09% |
| Dec 31, 2024 | 55 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioDlink International Company | 594 |
| Ocumension Therapeutics | 552 |
| Jiangsu Recbio Technology | 466 |
| Qyuns Therapeutics | 353 |
| Mirxes Holding Company | 347 |
| Jacobio Pharmaceuticals Group | 207 |
| Laekna | 83 |